XT
EGRX

XTX Topco’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

XTX Topco’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,594
Closed -$11.8K – 3306
2024
Q4 		$11.8K Buy
23,594
+1,157
+5% +$3.3K ﹤0.01% 2125
2024
Q3 		$83.7K Buy
22,437
+2,233
+11% +$10.7K 0.01% 1630
2024
Q2 		$113K Buy
+20,204
New +$88K 0.01% 1391
2024
Q1 		– Sell
-25,751
Closed -$135K – 2443
2023
Q4 		$135K Buy
25,751
+10,701
+71% +$106K 0.03% 1065
2023
Q3 		$237K Buy
+15,050
New +$270K 0.04% 906

Other funds holding EGRX

SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
AIC
Archer Investment Corporation Carmel, Indiana $469M AUM 19.1% 1-Year Est. Return